Recombinant Human LR3 IGF1

Recombinant Human LR3 IGF1

Size1:10μg price1:$38
Size2:50μg price2:$58
SKU: PCH2529 Category: Cytokines Tags: ,

Datasheet

Name

Recombinant Human LIF

Purity

Greater than 98% as determined by reducing SDS-PAGE

Endotoxin level

≤10 EU/mg

Construction

Recombinant Human LIF is produced by our Mammalian cell expression system and the target gene encoding Ser 23-Phe 202 is expressed.

Accession #

P15018

Host

Human Cells

Species

Human

Predicted Molecular Mass

19.7 kDa

Buffer

Lyophilized From PBS,5% mannitol and 0.01% Tween 80, pH7.4

Form

Shipping

The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below.

Stability&Storage

Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

Reconstitution

Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

 

 

 

Alternative Names

Leukemia Inhibitory Factor; LIF; Differentiation-Stimulating Factor; D Factor; Melanoma-Derived LPL Inhibitor; MLPLI; Emfilermin; LIF; HILDA

 

Background

Leukemia Inhibitory Factor (LIF) is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. LIF has a number of other activities including cholinergic neuron differentiation, control of stem cell pluripotency, bone and fat metabolism, mitogenesis of certain factor dependent cell lines and promotion of megakaryocyte production in vivo. Human and murine mature LIF exhibit a 78% sequence identity at the amino acid level. Human LIF is equally active on human and mouse cells. Murine LIF is approximately 1000 fold less active on human cells than human LIF.

 

Note

For Research Use Only , Not for Diagnostic Use.